Dr. Hima Bindu Kadiyala, MD

Dr. Kadiyala practices at Piedmont Medical Care Corporation in Woodstock, Georgia.

Dr. Kadiyala's NPI, 1235187071, was assigned on May 4, 2006. Dr. Kadiyala holds New Jersey license 25MA07894700.

Dr. Kadiyala's primary practice is Piedmont Medical Care Corporation, at 970 Woodstock Pkwy, Woodstock, GA 30188 in Cherokee County. The practice phone is (404) 658-9840.

Dr. Kadiyala's primary practice is Piedmont Medical Care Corporation in Woodstock, Georgia. Dr. Kadiyala is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Piedmont Physicians at Inman Park. Dmand AI also links Dr. Kadiyala to 5 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadiyala practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kadiyala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kadiyala is licensed in New Jersey.

CMS data shows 888 Medicare services from Dr. Kadiyala across 9 procedure codes in 2024, for 286 Medicare patients. Medicare paid $59,667 for them. Every service was in an office.

CMS counts 286 Medicare patients who saw Dr. Kadiyala in 2024. The largest group is 65 to 74, with 153 patients. 67% of them have high blood pressure, and 66% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kadiyala's median patient age at 54, with 66% women.

In 2024, Dr. Kadiyala wrote 5,714 Medicare Part D claims for 569 patients. 88% of them were for generic drugs. CMS names the drug for 5,053 of them, across 98 drugs with 11 or more claims each, at $173,227 in total drug cost. In 2023, CMS named 4,888 claims across 96 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kadiyala for performance year 2024, reported through an alternative payment model (APM). Dr. Kadiyala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kadiyala as offering telehealth.

CMS Open Payments shows 137 general payments to Dr. Kadiyala from 28 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $447.